• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增强恐惧消退:药理学方法。

Enhancing Fear Extinction: Pharmacological Approaches.

作者信息

Ponomareva Olga Y, Fenster Robert J, Ressler Kerry J

机构信息

McLean Hospital, Harvard Medical School, Belmont, MA, USA.

出版信息

Curr Top Behav Neurosci. 2023;64:289-305. doi: 10.1007/7854_2023_443.

DOI:10.1007/7854_2023_443
PMID:37584834
Abstract

Extinction is the process by which the memory of a learned conditioned association decreases over time and with introduction of new associations. It is a vital part of fear learning, and it is critical to recovery in multiple fear-related disorders, including Specific and Social Phobias, Panic Disorder, Obsessive Compulsive Disorder (OCD), and Posttraumatic Stress Disorder (PTSD). The process of extinction is also the underlying mechanism for recovery in gold-standard therapies for PTSD, including prolonged exposure, cognitive processing therapy, eye movement desensitization and procession, as well as other empirically-based paradigms. Pharmacological modulators of extinction are thus promising targets for treatment of fear-related disorders. We focus here on emerging psychopharmacological treatments to facilitate extinction: D-cycloserine, scopolamine, losartan, ketamine, and 3,4-methylenedioxymethamphetamine. We also provide an overview of recent advances in molecular pathways that show promise as targets for extincion and inhibitory learning, including pathways related to cannabinoid, brain-derived neurotrophic factor, hypothalamic-pituitary-adrenal signaling, and promising work in neurosteroid compounds.

摘要

消退是指习得的条件性关联记忆随着时间推移以及新关联的引入而逐渐减少的过程。它是恐惧学习的重要组成部分,对于多种与恐惧相关的疾病的恢复至关重要,这些疾病包括特定恐惧症和社交恐惧症、惊恐障碍、强迫症(OCD)以及创伤后应激障碍(PTSD)。消退过程也是PTSD金标准疗法恢复的潜在机制,这些疗法包括延长暴露疗法、认知加工疗法、眼动脱敏再处理疗法以及其他基于经验的范式。因此,消退的药理学调节剂有望成为治疗与恐惧相关疾病的靶点。我们在此重点关注促进消退的新兴精神药理学治疗方法:D-环丝氨酸、东莨菪碱、氯沙坦、氯胺酮和3,4-亚甲基二氧甲基苯丙胺。我们还概述了分子途径的最新进展,这些途径有望成为消退和抑制性学习的靶点,包括与大麻素、脑源性神经营养因子、下丘脑-垂体-肾上腺信号传导相关的途径,以及神经甾体化合物方面的有前景的研究工作。

相似文献

1
Enhancing Fear Extinction: Pharmacological Approaches.增强恐惧消退:药理学方法。
Curr Top Behav Neurosci. 2023;64:289-305. doi: 10.1007/7854_2023_443.
2
Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.用于恐惧、焦虑及创伤相关障碍暴露疗法的认知增强剂的药理学
Pharmacol Ther. 2015 May;149:150-90. doi: 10.1016/j.pharmthera.2014.12.004. Epub 2014 Dec 27.
3
Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder.增强针对焦虑症、强迫症和创伤后应激障碍的暴露疗法。
Expert Rev Neurother. 2014 Aug;14(8):893-910. doi: 10.1586/14737175.2014.934677. Epub 2014 Jun 27.
4
Fear extinction and BDNF: translating animal models of PTSD to the clinic.恐惧消退与脑源性神经营养因子:将 PTSD 的动物模型转化为临床治疗。
Genes Brain Behav. 2012 Jul;11(5):503-12. doi: 10.1111/j.1601-183X.2012.00801.x. Epub 2012 May 11.
5
Extinction learning in childhood anxiety disorders, obsessive compulsive disorder and post-traumatic stress disorder: implications for treatment.儿童焦虑症、强迫症和创伤后应激障碍中的消退学习:对治疗的启示
Expert Rev Neurother. 2016 Oct;16(10):1155-74. doi: 10.1080/14737175.2016.1199276. Epub 2016 Jun 27.
6
From the neurobiology of extinction to improved clinical treatments.从消退的神经生物学到改进的临床治疗。
Depress Anxiety. 2014 Apr;31(4):279-90. doi: 10.1002/da.22214. Epub 2013 Nov 20.
7
Pharmacological enhancement of behavioral therapy: focus on posttraumatic stress disorder.行为疗法的药理学增强:聚焦创伤后应激障碍
Curr Top Behav Neurosci. 2010;2:279-99. doi: 10.1007/7854_2009_10.
8
Randomized controlled experimental study of hydrocortisone and D-cycloserine effects on fear extinction in PTSD.随机对照实验研究地塞米松和 D-环丝氨酸对 PTSD 中恐惧消退的影响。
Neuropsychopharmacology. 2022 Oct;47(11):1945-1952. doi: 10.1038/s41386-021-01222-z. Epub 2021 Nov 19.
9
The BDNF Val66Met polymorphism moderates the relationship between Posttraumatic Stress Disorder and fear extinction learning.脑源性神经营养因子 Val66Met 多态性调节创伤后应激障碍与恐惧消退学习之间的关系。
Psychoneuroendocrinology. 2018 May;91:142-148. doi: 10.1016/j.psyneuen.2018.03.002. Epub 2018 Mar 6.
10
Angiotensin type 1 receptor inhibition enhances the extinction of fear memory.1型血管紧张素受体抑制增强恐惧记忆的消退。
Biol Psychiatry. 2014 Jun 1;75(11):864-72. doi: 10.1016/j.biopsych.2013.08.024. Epub 2013 Oct 4.

本文引用的文献

1
Pharmacological Enhancement of Extinction Retention in Non-stressed Adolescent Rats but Not Those Exposed to Chronic Corticosterone.非应激状态下青春期大鼠而非长期暴露于皮质酮的大鼠中消退记忆保持的药理学增强作用。
Front Neurosci. 2022 Mar 16;16:822709. doi: 10.3389/fnins.2022.822709. eCollection 2022.
2
Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial.与剂量相关的氯胺酮对退伍军人和现役军人创伤后应激障碍抗抑郁症状的疗效:一项双盲、随机、安慰剂对照、多中心临床试验。
Neuropsychopharmacology. 2022 Jul;47(8):1574-1581. doi: 10.1038/s41386-022-01266-9. Epub 2022 Jan 19.
3
Pre-treatment hippocampal functioning impacts context renewal for cholinergic modulated exposure therapy.
治疗前海马功能影响胆碱能调制暴露疗法的情境更新。
Biol Psychol. 2021 Oct;165:108167. doi: 10.1016/j.biopsycho.2021.108167. Epub 2021 Oct 5.
4
Targeting the Endocannabinoid System in the Treatment of Posttraumatic Stress Disorder: A Promising Case of Preclinical-Clinical Translation?靶向创伤后应激障碍的内源性大麻素系统:临床前-临床转化的有希望案例?
Biol Psychiatry. 2022 Feb 1;91(3):262-272. doi: 10.1016/j.biopsych.2021.07.019. Epub 2021 Jul 24.
5
Allopregnanolone Mediates Affective Switching Through Modulation of Oscillatory States in the Basolateral Amygdala.醛固酮通过调节外侧杏仁核的振荡状态介导情感转换。
Biol Psychiatry. 2022 Feb 1;91(3):283-293. doi: 10.1016/j.biopsych.2021.07.017. Epub 2021 Jul 27.
6
Randomized, Placebo-Controlled Trial of the Angiotensin Receptor Antagonist Losartan for Posttraumatic Stress Disorder.随机、安慰剂对照试验评估血管紧张素受体拮抗剂氯沙坦治疗创伤后应激障碍。
Biol Psychiatry. 2021 Oct 1;90(7):473-481. doi: 10.1016/j.biopsych.2021.05.012. Epub 2021 May 21.
7
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.MDMA 辅助治疗严重 PTSD:一项随机、双盲、安慰剂对照的 3 期研究。
Nat Med. 2021 Jun;27(6):1025-1033. doi: 10.1038/s41591-021-01336-3. Epub 2021 May 10.
8
Low Dose Ketamine Infusion for Comorbid Posttraumatic Stress Disorder and Chronic Pain: A Randomized Double-Blind Clinical Trial.低剂量氯胺酮输注治疗创伤后应激障碍合并慢性疼痛:一项随机双盲临床试验。
Chronic Stress (Thousand Oaks). 2020 Dec 22;4:2470547020981670. doi: 10.1177/2470547020981670. eCollection 2020 Jan-Dec.
9
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.一项重复使用氯胺酮治疗慢性创伤后应激障碍的随机对照试验。
Am J Psychiatry. 2021 Feb 1;178(2):193-202. doi: 10.1176/appi.ajp.2020.20050596. Epub 2021 Jan 5.
10
The renin-angiotensin system in PTSD: a replication and extension.创伤后应激障碍中的肾素-血管紧张素系统:一项重复与扩展研究。
Neuropsychopharmacology. 2021 Mar;46(4):750-755. doi: 10.1038/s41386-020-00923-1. Epub 2020 Dec 14.